arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Editas Medicine, Inc.

EDIT

$2.87 ▼ -0.03 (-1.20%) at close

13 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Editas Medicine, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $254.7M

Dividend Yield —

Revenue Growth 25.4% ↗

Op. Margin -394.9%

ROIC -156.3% ↘

FCF / Share $-1.87 ↗

Trailing P/E —

Price / Book 10.3x

FCF Yield —

Debt / Equity 1.96

info Valuation on last close. End-of-day price, Aug 7, 2026.

13-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$40.52M

↑ +25.4% —

Net Income Profit after all expenses

$-160.06M

↑ +32.5% —

Operating Margin Operating profit as % of sales

-394.9%

↓ -82.3% 0th

FCF / Share Free cash flow per share

$-1.87

↑ +29.8% —

Long-Term Debt Long-term obligations

$53.60M

↓ -6.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)
Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue Growth YoY (%)	25.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+217%)	-58.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-833%)	296.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3604%)	-22.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-385%)	-71.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-998%)	341.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4174%)	-35.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-546%)	132.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1558%)	—	—	—	—	—
EPS Growth YoY (%)	37.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-42.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	37.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-12.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-43.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	32.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-54.7% Weak ↓ Weak Declining Year-over-year change in net income	30.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-14.5% Weak ↑ Weak Improving Year-over-year change in net income	-66.0% Weak ↓ Weak Declining Year-over-year change in net income	13.3% Fair ↑ Fair Improving Year-over-year change in net income	-21.6% Weak ↓ Weak Declining Year-over-year change in net income	8.6% Fair ↑ Fair Improving Year-over-year change in net income	-23.8% Weak ↑ Weak Improving Year-over-year change in net income	-33.3% Weak Weak Year-over-year change in net income	-432.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	29.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-47.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	31.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-4.0% Weak Weak Year-over-year change in free cash flow	20.4% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	27.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	8.2% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	-4.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-1.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-7.2% Weak Weak Compound annual revenue growth over 3 years	87.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-14.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	9.5% Good ↓ Good Declining Compound annual revenue growth over 5 years	19.6% Excellent Excellent Compound annual revenue growth over 5 years	7.5% Fair Fair Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Operating Margin (%) (%)	-394.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2733%)	—	-216.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1544%)	—	—	-148.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1091%)	—	-356.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2474%)	—	—	—	—	—
Profit Margin (%) (%)	-395.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3392%)	—	-196.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1734%)	—	—	-127.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1165%)	—	-344.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2969%)	—	—	—	—	—
FCF Margin (%) (%)	-409.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-175.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-206.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-228.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-158.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-83.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.61x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Return on Invested Capital (%)	-156.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-103.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-42.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-45.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	33.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	65.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-85.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-73.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-42.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-23.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	—	-176.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1277%)	-43.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-393%)	-61.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-507%)	-34.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-332%)	-29.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-296%)	-51.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-440%)	-46.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-410%)	-57.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-486%)	-72.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-581%)	87.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+485%)	89.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+497%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Debt to Equity (x)	1.96x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+227%)	0.43x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-29%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-25.93x Weak Weak Operating income divided by interest expense Optimal: > 5x	-118.02x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	-209.01x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-93.04M	$-74.11M	$-123.65M	$-141.52M	$-203.52M	$-139.68M	$-238.18M	$-134.78M	$-146.63M	$-185.32M	$-143.18M	$-10.62M	$-2.01M
Debt / EBITDA (x)	-0.35x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.23x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue per Share (USD)	$0.46	$0.39	$1.03	$0.29	$0.38	$1.55	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.80	$-2.88	$-2.02	$-3.21	$-2.85	$-1.98	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.87	$-2.66	$-1.80	$-2.64	$-2.54	$-3.19	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.28	$1.62	$4.27	$5.24	$8.09	$6.29	$4.83	$4.84	$4.68	$3.76	$-25.70	—	—
Tangible Book Value per Share (USD)	$0.28	$1.62	$4.27	$5.24	$8.09	$6.29	$4.83	$4.84	$4.68	$3.76	$-25.70	—	—
Basic Weighted Avg Shares (shares)	88.75M	82.34M	75.97M	68.66M	67.62M	58.61M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Working Capital (USD)	$117.65M	$212.09M	$277.61M	$296.64M	$460.43M	$360.88M	$403.88M	$338.88M	$295.49M	$154.10M	$138.06M	—	—
LT Debt (USD)	$53.60M	$57.43M	$0.00	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$27.29M	$134.27M	$349.10M	$360.68M	$553.64M	$393.59M	$262.44M	$236.16M	$208.08M	$134.61M	$-83.11M	$-15.29M	$-1.76M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Sales/Revenue/Turnover (USD)	$40.52M	$32.31M	$78.12M	$19.71M	$25.54M	$90.73M	$20.53M	$31.94M	$13.73M	—	—	—	—
Depreciation Expense (USD)	$5.28M	$5.81M	$6.06M	$6.34M	$5.05M	$3.96M	$2.83M	$3.25M	$2.68M	$1.20M	$471.00K	$157.00K	—
Net Income, GAAP (USD)	$-160.06M	$-237.09M	$-153.22M	$-220.43M	$-192.50M	$-115.98M	$-133.75M	$-109.95M	$-120.32M	$-97.18M	$-72.90M	$-13.69M	—
Operating Cash Flow (USD)	$-165.24M	$-210.28M	$-132.18M	$-177.35M	$-163.80M	$-179.84M	$-40.67M	$-45.71M	$-9.42M	$-50.25M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 47 quarters

Editas Medicine, Inc.

Analytical Summary

13-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare EDIT with peers